The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 756 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 32.7

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 15-19

Both Sexes
Site 1975-2013 2004-2013
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 14,842 20.6 0.6* 4,395 22.2 0.6*
1. Leukemias 1,757 2.4 0.7* 520 2.6 0.7*
2. Lymphomas 3,659 5.1 0.0 1,006 5.1 0.0
3. CNS, intracranial, intraspinal 1,440 2.0 0.4 413 2.1 0.4
4. Osseous & chondromatous neoplasms 1,146 1.6 0.5 326 1.6 0.5
5. Soft tissue sarcomas 1,070 1.5 0.2 303 1.5 0.2
6. Germ cell and trophoblastic neoplasms 1,803 2.5 0.9* 552 2.8 0.9*
7. Melanoma and skin carcinomas 1,088 1.5 0.7* 308 1.6 0.7*
8. Carcinomas (excluding skin) 2,591 3.6 2.0* 891 4.5 6.0*
9. Miscellaneous specified neoplasms, NOS 232 0.3 0.4 71 0.4 0.4
10. Unspecified malignant neoplasms 56 0.1 - - - -
Males
Site 1975-2013 2004-2013
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 7,799 21.2 0.6* 2,304 22.7 0.6*
1. Leukemias 1,047 2.8 0.4 300 3.0 0.4
2. Lymphomas 1,966 5.3 0.2 551 5.4 0.2
3. CNS, intracranial, intraspinal 828 2.3 0.3 226 2.2 0.3
4. Osseous & chondromatous neoplasms 755 2.1 0.8* 216 2.1 0.8*
5. Soft tissue sarcomas 567 1.5 0.2 156 1.5 0.2
6. Germ cell and trophoblastic neoplasms 1,327 3.6 1.2* 433 4.3 1.2*
7. Melanoma and skin carcinomas 436 1.2 1.0* 129 1.3 1.0*
8. Carcinomas (excluding skin) 744 2.0 1.6* 258 2.5 1.6*
9. Miscellaneous specified neoplasms, NOS 104 0.3 - 33 0.3 -
10. Unspecified malignant neoplasms 25 0.1 - - - -
Females
Site 1975-2013 2004-2013
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 7,043 20.0 0.5* 2,091 21.7 0.5*
1. Leukemias 710 2.0 1.2* 220 2.3 1.2*
2. Lymphomas 1,693 4.8 -0.1 455 4.7 -0.1
3. CNS, intracranial, intraspinal 612 1.7 0.5 187 1.9 0.5
4. Osseous & chondromatous neoplasms 391 1.1 0.1 110 1.1 0.1
5. Soft tissue sarcomas 503 1.4 0.2 147 1.5 0.2
6. Germ cell and trophoblastic neoplasms 476 1.4 -0.2 119 1.2 -0.2
7. Melanoma and skin carcinomas 652 1.9 0.4 179 1.9 0.4
8. Carcinomas (excluding skin) 1,847 5.2 2.0* 633 6.6 7.3*
9. Miscellaneous specified neoplasms, NOS 128 0.4 - 38 0.4 -
10. Unspecified malignant neoplasms 31 0.1 - - - -

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2013.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.